Cingulate (CING) Shares Outstanding (Diluted) (2022 - 2026)
Cingulate (CING) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 64.41 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 115.80 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 138.28 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 556.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Cingulate | 70.68 Mn | 70.68 Mn | - | 13.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Mn |
| Dec 31, 2025 | 5.06 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 4.39 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 586,313.00 |
| Mar 31, 2024 | 412,109.00 |
| Dec 31, 2023 | 75,432.00 |
| Sep 30, 2023 | 82,358.00 |
| Jun 30, 2023 | 48,726.00 |
| Mar 31, 2023 | 47,121.00 |
| Dec 31, 2022 | 50,193.00 |
| Sep 30, 2022 | 47,121.00 |
| Jun 30, 2022 | 47,121.00 |